← Leaderboards
Lei Zheng
Johns Hopkins University
$11,028,048
Attributed
$13,026,080
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2010–25$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,444,830 · 6
By mechanism
R01$7,594,852 · 2
P30$4,418,750 · 1
T32$2,851,016 · 1
P01$1,691,912 · 1
K23$888,300 · 1
Top collaborators
- Elizabeth Marion Jaffee8 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Elizabeth Marion Jaffee$29,780,612
- Neeha Zaidi$2,679,841
- Chi V. Dang$24,535,395
- Dung T Le$5,608,820
- Patrizio Caturegli$4,739,009
Others in their field
Top investigators on “Pancreatic Ductal Adenocarcinoma”
- Anirban Maitra · Johns Hopkins University$27,617,954
- Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr$17,689,051
- Sunil R Hingorani · Fred Hutchinson Cancer Research Center$15,005,509
- David Tuveson · University Of Pennsylvania$13,334,563
- Channing J Der · University Of North Carolina Chapel Hill$12,699,348
- David G Denardo · Washington University$12,568,412
Research focus
Pancreatic Ductal AdenocarcinomaTumorMalignant Neoplasm Of PancreasTumor MicroenvironmentCellsImmuneResponseMalignant NeoplasmsPathway InteractionsSignal TransductionMouse ModelNeoplastic CellImmunohistochemistryAntibodiesInfiltrationT-LymphocyteResectableNeoadjuvant TherapyPancreatic NeoplasmClinical TrialsImmunotherapyResectedRegulatory T-LymphocyteVaccines
Grant awards (37)
Mays Cancer Center at UT Health SA$2,227,050
P30 · FY2025 · CA · contact PI
Integration of stromal targeting agents with immune checkpoint therapy$344,496
P01 · FY2025 · CA · contact PI
Mays Cancer Center at UT Health SA$2,191,700
P30 · FY2024 · CA · contact PI
Integration of stromal targeting agents with immune checkpoint therapy$327,273
P01 · FY2024 · CA · contact PI
Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial$552,880
R01 · FY2023 · CA · contact PI
Clinical and Laboratory Research Training for Surgical Oncologists$519,319
T32 · FY2023 · CA · contact PI
Interrogate the interaction between tumor cells and nerves in the tumor microenvironment of pancreatic cancer$358,778
R01 · FY2023 · CA · contact PI
Integration of stromal targeting agents with immune checkpoint therapy$337,607
P01 · FY2023 · CA · contact PI
Interrogate the interaction between tumor cells and nerves in the tumor microenvironment of pancreatic cancer$21,497
R01 · FY2023 · CA · contact PI
Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial$556,932
R01 · FY2022 · CA · contact PI
Clinical and Laboratory Research Training for Surgical Oncologists$447,765
T32 · FY2022 · CA · contact PI
Interrogate the interaction between tumor cells and nerves in the tumor microenvironment of pancreatic cancer$381,128
R01 · FY2022 · CA · contact PI
Integration of stromal targeting agents with immune checkpoint therapy$338,040
P01 · FY2022 · CA · contact PI
Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial$581,039
R01 · FY2021 · CA · contact PI
Clinical and Laboratory Research Training for Surgical Oncologists$457,466
T32 · FY2021 · CA · contact PI
Interrogate the interaction between tumor cells and nerves in the tumor microenvironment of pancreatic cancer$388,906
R01 · FY2021 · CA · contact PI
Integration of stromal targeting agents with immune checkpoint therapy$344,496
P01 · FY2021 · CA · contact PI
Clinical and Laboratory Research Training for Surgical Oncologists$531,054
T32 · FY2020 · CA · contact PI
Interrogate the interaction between tumor cells and nerves in the tumor microenvironment of pancreatic cancer$388,906
R01 · FY2020 · CA · contact PI
Reprogramming the pancreatic tumor microenvironment with immunotherapy$590,123
R01 · FY2019 · CA · contact PI
Interrogate the interaction between tumor cells and nerves in the tumor microenvironment of pancreatic cancer$388,906
R01 · FY2019 · CA · contact PI
Clinical and Laboratory Research Training for Surgical Oncologists$457,210
T32 · FY2018 · CA · contact PI
Reprogramming the pancreatic tumor microenvironment with immunotherapy$436,026
R01 · FY2018 · CA · contact PI
Clinical and Laboratory Research Training for Surgical Oncologists$438,202
T32 · FY2017 · CA · contact PI
Reprogramming the pancreatic tumor microenvironment with immunotherapy$429,841
R01 · FY2017 · CA · contact PI
Annexin A2 as a mediator of pancreatic cancer metastases$336,150
R01 · FY2017 · CA · contact PI
Reprogramming the pancreatic tumor microenvironment with immunotherapy$424,612
R01 · FY2016 · CA · contact PI
Annexin A2 as a mediator of pancreatic cancer metastases$336,150
R01 · FY2016 · CA · contact PI
Reprogramming the pancreatic tumor microenvironment with immunotherapy$424,612
R01 · FY2015 · CA · contact PI
Annexin A2 as a mediator of pancreatic cancer metastases$336,150
R01 · FY2015 · CA · contact PI
Annexin A2 as a mediator of pancreatic cancer metastases$326,066
R01 · FY2014 · CA · contact PI
Dissecting the mechanisms of immune tolerance within the pancreatic tumor's micro$178,200
K23 · FY2014 · CA · contact PI
Annexin A2 as a mediator of pancreatic cancer metastases$336,150
R01 · FY2013 · CA · contact PI
Dissecting the mechanisms of immune tolerance within the pancreatic tumor's micro$178,200
K23 · FY2013 · CA · contact PI
Dissecting the mechanisms of immune tolerance within the pancreatic tumor's micro$178,200
K23 · FY2012 · CA · contact PI
Dissecting the mechanisms of immune tolerance within the pancreatic tumor's micro$178,200
K23 · FY2011 · CA · contact PI
Dissecting the mechanisms of immune tolerance within the pancreatic tumor's micro$175,500
K23 · FY2010 · CA · contact PI